German regulator puts UniQure gene therapy appraisal on hold

German regulator puts UniQure gene therapy appraisal on hold. REUTERS. FRANKFURT, April 17

(Reuters) - A German regulator for new drugs has suspended the assessment of the Western world's first gene therapy, UniQure's Glybera, after an adviser to the European drugs watchdog voiced concern over the treatment. (Read more)